News

In a follow-up analysis to the pivotal TOPAZ-1 study, which established the combination therapy of durvalumab (an ...
Bitcoin Depot Inc. BTM shares have skyrocketed 250.6% this year, significantly outperforming the industry, the Zacks Finance ...
In a follow-up analysis to the pivotal TOPAZ-1 study, which established the combination therapy of durvalumab (an immunotherapy drug) plus gemcitabine and cisplatin (GemCis, chemotherapy drugs) as the ...